Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker EBS
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 4, 2026 | EBS Emergent BioSolutions Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 2, 2026 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 2, 2026 | EBS Emergent BioSolutions Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 16, 2026 | EBS Emergent BioSolutions Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 14, 2026 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 1, 2026 | EBS Emergent BioSolutions Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 5, 2026 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 5, 2026 | EBS Emergent BioSolutions Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 5, 2026 | EBS Emergent BioSolutions Inc. | 2.05 Costs Associated with Exit or Disposal Activities | 8-K | 8-K ↗ |
| Aug 5, 2026 | EBS Emergent BioSolutions Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 29, 2026 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 29, 2026 | EBS Emergent BioSolutions Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 30, 2026 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 30, 2026 | EBS Emergent BioSolutions Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 30, 2026 | EBS Emergent BioSolutions Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Apr 17, 2026 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 17, 2026 | EBS Emergent BioSolutions Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Apr 17, 2026 | EBS Emergent BioSolutions Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 17, 2026 | EBS Emergent BioSolutions Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 3, 2026 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 3, 2026 | EBS Emergent BioSolutions Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 26, 2026 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 26, 2026 | EBS Emergent BioSolutions Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 14, 2026 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 12, 2026 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 12, 2025 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2025 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2025 | EBS Emergent BioSolutions Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 29, 2025 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 29, 2025 | EBS Emergent BioSolutions Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 11, 2025 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 11, 2025 | EBS Emergent BioSolutions Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Sep 5, 2025 | EBS Emergent BioSolutions Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 6, 2025 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 6, 2025 | EBS Emergent BioSolutions Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 24, 2025 | EBS Emergent BioSolutions Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 23, 2025 | EBS Emergent BioSolutions Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 7, 2025 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 7, 2025 | EBS Emergent BioSolutions Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 6, 2025 | EBS Emergent BioSolutions Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Mar 31, 2025 | EBS Emergent BioSolutions Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 24, 2025 | EBS Emergent BioSolutions Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 10, 2025 | EBS Emergent BioSolutions Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 10, 2025 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 3, 2025 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 3, 2025 | EBS Emergent BioSolutions Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 15, 2025 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 14, 2025 | EBS Emergent BioSolutions Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 8, 2025 | EBS Emergent BioSolutions Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 6, 2024 | EBS Emergent BioSolutions Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:23 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances